Authors
Loading...
Preclinical study demonstrates potent in vitro activity of novel carbolines against Plasmodium falciparum, indicating poor drug-like properties hinder oral efficacy in mouse models.
Almolhim et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: